What is Intent Solutions?
Intent Solutions, headquartered in Atlanta, operates at the intersection of technology, software, and data services. The company is dedicated to mitigating the misuse, abuse, and diversion of prescription medications, with a particular focus on opioids. Their innovative product, tadtm, facilitates secure medicine delivery, providing advanced adherence tracking and valuable insights for clinical trial studies. This technology serves researchers, clinicians, and organizations engaged in clinical trials and patient adherence programs, aiming to enhance both medication safety and efficacy.
How much funding has Intent Solutions raised?
Intent Solutions has raised a total of $4.2M across 2 funding rounds:
Angel/Seed
$1.5M
Private Equity
$2.7M
Angel/Seed (2016): $1.5M, investors not publicly disclosed
Private Equity (2017): $2.7M, investors not publicly disclosed
What's next for Intent Solutions?
The recent major strategic investment signals a pivotal growth phase for Intent Solutions. This capital infusion is expected to accelerate the development and deployment of their medication safety and adherence solutions. The company is well-positioned to expand its reach within the clinical research and healthcare sectors, leveraging its technology to address critical issues in prescription drug management and patient compliance. Future initiatives will likely focus on enhancing the tadtm platform and forging deeper partnerships with key stakeholders in the pharmaceutical and research industries.
See full Intent Solutions company page
